Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.

Fatease AA, Abdelkader H, Fathalla Z, Mousa HS, Abdel-Aleem JA, Abou-Taleb HA

Open source

DOI
10.1080/10837450.2026.2757869
Published
2026 Nov 3
Container
Pharmaceutical development and technology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10837450.2026.2757869,
  title = {Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.},
  author = {Fatease AA and Abdelkader H and Fathalla Z and Mousa HS and Abdel-Aleem JA and Abou-Taleb HA},
  year = {2026},
  journal = {Pharmaceutical development and technology},
  doi = {10.1080/10837450.2026.2757869},
  url = {https://doi.org/10.1080/10837450.2026.2757869}
}

RIS

TY  - JOUR
TI  - Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.
AU  - Fatease AA
AU  - Abdelkader H
AU  - Fathalla Z
AU  - Mousa HS
AU  - Abdel-Aleem JA
AU  - Abou-Taleb HA
PY  - 2026
JO  - Pharmaceutical development and technology
DO  - 10.1080/10837450.2026.2757869
UR  - https://doi.org/10.1080/10837450.2026.2757869
ER  - 

APA

AA, F., H, A., Z, F., HS, M., JA, A., & HA, A. (2026). Enhanced bioavailability and gastric protection of the NSAIDs meloxicam-cyclodextrin microparticles.. Pharmaceutical development and technology. https://doi.org/10.1080/10837450.2026.2757869

Source records